Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Monlunabant

Study of INV-202 in Patients With Obesity and Metabolic Syndrome

Inversago Pharma · Phase 2 · Completed · Enrollment 243

NCT05891834

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Low dosen/rn/rn/rn/r
High dosen/rn/rn/rn/r
Placebon/rn/rn/rn/r
Middle Dosen/rn/rn/rn/r

Not shown

  • Low dose: endpoint not reported
  • High dose: endpoint not reported
  • Placebo: endpoint not reported
  • Middle Dose: endpoint not reported